|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
11/15/2010 8:06:27 AM
Sarasota, FL, November 15, 2010 --(PR.com)-- M.G. Urbanski of Global-Med Technologies Group (GTG) invites interested members of the public to visit GTG’s new corporate headquarters on St. Armands Circle in Sarasota, Florida. The new office maintains normal business hours of operation and is open from 9:00 AM – 5:00 PM Mon-Fri. Formally the Regions Bank building, GTG is located at 443 John Ringling Blvd in Suite F on the second floor of the newly renovated 443 St. Armands corner complex.
"We are excited to be opening our headquarters in St. Armands Circle, because I really believe it’s time for this type of world class medical device development here in Sarasota," Urbanski said. "Our group concerns itself exclusively with seeking cutting edge medical technologies and infusing them into our wholly owned subsidiaries. We are happy to bring this economic growth opportunity to the community and look forward to working with leading surgeons locally. St. Armands provides an excellent environment for our business to engage the worldwide market."
GTG is a technologies-driven, research-based private holding group exclusively focused on the orthopaedic and musculoskeletal device sector. GTG provides surgeons and health professionals with clinically relevant, innovative and cost-effective products that improve the quality of life for patients. They focus on devices and procedures that are minimally invasive in nature and therefore, less traumatic to the patient. GTG’s subsidiary product lines include biologic, orthopaedic, spine, neurosurgical and other musculoskeletal devices and/or procedures that are indicated for repair, reconstruction and regeneration of bones, joints and surrounding soft tissues. The Company is researching and developing non-invasive procedures and treatments for osteoporosis and other age related degenerative diseases. It’s committed to the development of pre-operative, operative and post- operative procedures, devices and monitoring systems that reduce cost while providing surgeon and patient less traumatic surgical intervention options.
For more information, the GTG web site is located at www.global-med.us.com. We are members of the Greater Sarasota Chamber of Commerce and the St. Armands Circle Association.
|
|
|
|
|
|
|
|
|
|
|